Neural regeneration research
Cochlear amyloid beta 42-mediated hearing loss: A marker of preclinical Alzheimer's disease.
Dheyaa Al-Sallami, Shelley Tischkau, Raheem F H Al Aameri, Leonard P Rybak
Published: 202610.4103/NRR.NRR-D-25-01128
No abstract available for this study.